AQA
CRL icon

Alpha Quant Advisors’s Charles River Laboratories CRL Stock Holding History

Alpha Quant Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$21K Hold
145
– – 0.02% 154
2018
Q4 		$16K Buy
+145
New +$18.2K 0.02% 182

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Alpha Quant Advisors's CRL Position: Q1 2019 in Review

Alpha Quant Advisors held its Charles River Laboratories (CRL) position steady in Q1 2019 at 145 shares worth $21K. The position accounts for 0.02% of the portfolio, ranked #154.

Alpha Quant Advisors first reported a position in CRL in Q4 2018 and has held it in 2 quarters since. 409 funds tracked by Wall St. Rank hold CRL as of Q1 2019.

  • Alpha Quant Advisors held 145 shares of Charles River Laboratories worth $21K as of Q1 2019.
  • Alpha Quant Advisors left its Charles River Laboratories share count unchanged in Q1 2019.
  • Charles River Laboratories made up 0.02% of Alpha Quant Advisors's portfolio in Q1 2019, its #154 holding.
  • Alpha Quant Advisors first reported a position in Charles River Laboratories in Q4 2018 and has held it in 2 quarters since.
  • 409 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.